Publications
A novel way to quantify schizophrenia symptoms in clinical trials
Oleg Medvedev, Michael Berk, Olivia Dean, Ellie Brown, Margaret Sandham, Joanna Dipnall, Robert McNamara, Alexander Sumich, Christian Krägeloh, Ajit Narayanan, Richard Siegert
(2021), Vol. 51, pp. 1-8, European journal of clinical investigation, Chichester, Eng., C1
B Kavanagh, M Ashton, S Cowdery, O Dean, A Turner, M Berk, S Gwini, S Brennan-Olsen, H Koivumaa-Honkanen, A Chanen, L Williams
(2021), Vol. 279, pp. 711-721, Journal of affective disorders, Amsterdam, The Netherlands, C1
C Moller, S Cotton, P Badcock, S Hetrick, M Berk, O Dean, A Chanen, C Davey
(2021), Vol. 281, pp. 714-720, Journal of affective disorders, Amsterdam, The Netherlands, C1
T Purton, L Staskova, M Lane, S Dawson, M West, J Firth, G Clarke, J Cryan, M Berk, A O'Neil, O Dean, A Hadi, C Honan, W Marx
(2021), Vol. 123, pp. 1-13, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
L Arancini, R Borland, M Le Grande, M Mohebbi, S Dodd, O Dean, M Berk, A McNeill, G Fong, K Cummings
(2021), pp. 1-12, Addiction, London, Eng., C1
Improvement of cognitive function in schizophrenia with N-acetylcysteine: a theoretical review
C Yolland, A Phillipou, D Castle, E Neill, M Hughes, C Galletly, Z Smith, P Francis, O Dean, J Sarris, D Siskind, A Harris, S Rossell
(2020), Vol. 23, pp. 139-148, Nutritional neuroscience, Abingdon, Eng., C1
Nikolaj Travica, Nathan D'Cunha, Nenad Naumovski, Katherine Kent, Duane Mellor, Joseph Firth, Ekavi Georgousopoulou, Olivia Dean, Amy Loughman, Felice Jacka, Wolfgang Marx
(2020), Vol. 85, pp. 96-105, Brain, behavior and immunity, Amsterdam, The Netherlands, C1
Bianca Kavanagh, Lana Williams, Michael Berk, Alyna Turner, Henry Jackson, Mohammadreza Mohebbi, Buranee Kanchanatawan, Melanie Ashton, Chee Ng, Michael Maes, Lesley Berk, Gin Malhi, Nathan Dowling, Ajeet Singh, Olivia Dean
(2020), Vol. 42, pp. 14-21, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1
M Ashton, O Dean, W Marx, M Mohebbi, M Berk, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, M Hopwood, K Faye-Chauhan, Y Kim, S Dash, F Jacka, N Shivappa, J Hebert, A Turner
(2020), Vol. 54, pp. 159-172, Australian and New Zealand journal of psychiatry, London, Eng., C1
W Marx, M Hockey, A McGuinness, M Lane, J Christodoulou, I van der Mei, M Berk, O Dean, B Taylor, S Broadley, J Lechner-Scott, F Jacka, R Lucas, A Ponsonby
(2020), Vol. 37, pp. 1-16, Multiple sclerosis and related disorders, Amsterdam, The Netherlands, C1
M Ashton, M Mohebbi, A Turner, W Marx, M Berk, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, M Hopwood, B Stubbs, O Dean
(2020), Vol. 65, pp. 306-318, Canadian journal of psychiatry, London, Eng., C1
C Yolland, D Hanratty, E Neill, S Rossell, M Berk, O Dean, D Castle, E Tan, A Phillipou, A Harris, A Barreiros, A Hansen, D Siskind
(2020), Vol. 54, pp. 453-466, Australian and New Zealand journal of psychiatry, London, Eng., C1
M Berk, M Mohebbi, O Dean, S Cotton, A Chanen, S Dodd, A Ratheesh, G Amminger, M Phelan, A Weller, A Mackinnon, F Giorlando, S Baird, L Incerti, R Brodie, N Ferguson, S Rice, M Schäfer, E Mullen, S Hetrick, M Kerr, S Harrigan, A Quinn, C Mazza, P McGorry, C Davey
(2020), Vol. 18, pp. 1-12, BMC medicine, London, Eng., C1
C Bortolasci, W Marx, A Walker, K Hasebe, B Kavanagh, M Morris, M Mohebbi, A Turner, L Gray, L Berk, K Walder, M Berk, O Dean
(2020), Vol. 10, pp. 1-4, BMJ open, London, Eng., C1
K Fountoulakis, E Dragioti, A Theofilidis, T Wiklund, X Atmatzidis, I Nimatoudis, E Thys, M Wampers, L Hranov, T Hristova, D Aptalidis, R Milev, F Iftene, F Spaniel, P Knytl, P Furstova, T From, H Karlsson, M Walta, R Salokangas, J Azorin, J Bouniard, J Montant, G Juckel, I Haussleiter, A Douzenis, I Michopoulos, P Ferentinos, N Smyrnis, L Mantonakis, Z Nemes, X Gonda, D Vajda, A Juhasz, A Shrivastava, J Waddington, M Pompili, A Comparelli, V Corigliano, E Rancans, A Navickas, J Hilbig, L Bukelskis, L Stevovic, S Vodopic, O Esan, O Oladele, C Osunbote, J Rybakowski, P Wojciak, K Domowicz, M Figueira, L Linhares, J Crawford, A Panfil, D Smirnova, O Izmailova, D Lecic-Tosevski, H Temmingh, F Howells, J Bobes, M Garcia-Portilla, L Garciá-Alvarez, G Erzin, H Karada, A De Sousa, A Bendre, C Hoschl, C Bredicean, I Papava, O Vukovic, B Pejuskovic, V Russell, L Athanasiadis, A Konsta, D Stein, M Berk, O Dean, R Tandon, S Kasper, M De Hert
(2020), pp. 1-9, CNS Spectrums, Bristol, Eng., C1
J Lotter, M Möller, O Dean, M Berk, B Harvey
(2020), Vol. 11, pp. 1-15, Frontiers in psychiatry, Lausanne, Switzerland, C1
C Bortolasci, C Voigt, A Turner, M Mohebbi, L Gray, S Dodd, K Walder, M Berk, S Cotton, G Malhi, C Ng, N Dowling, J Sarris, O Dean
(2020), Vol. 32, pp. 313-320, Acta Neuropsychiatrica, Cambridge, Eng., C1
Personality disorder increases risk of low quality of life among women with mental state disorders
B Kavanagh, A Stuart, M Berk, A Turner, O Dean, J Pasco, H Jackson, H Koivumaa-Honkanen, A Chanen, L Williams
(2020), Vol. 102, pp. 152193-152193, Comprehensive Psychiatry, Amsterdam, The Netherlands, C1
Insight in substance use disorder: a systematic review of the literature
D Raftery, P Kelly, F Deane, A Baker, I Ingram, M Goh, D Lubman, G Carter, A Turner, O Dean, B Sinclair, R McKetin
(2020), Vol. 111, pp. 1-9, Addictive behaviors, Amsterdam, The Netherlands, C1
Wolfgang Marx, Andrew Scholey, Joseph Firth, Nathan D’Cunha, Melissa Lane, Meghan Hockey, Melanie Ashton, John Cryan, A O'Neil, Nenad Naumovski, Michael Berk, Olivia Dean, Felice Jacka
(2020), Vol. 118, pp. 472-484, Neuroscience & Biobehavioral Reviews, Amsterdam, The Netherlands, C1
M Ashton, B Kavanagh, W Marx, M Berk, J Sarris, C Ng, M Hopwood, L Williams, O Dean
(2020), pp. 1-12, Canadian journal of psychiatry, London, Eng., C1
R McKetin, B Quinn, P Higgs, M Berk, O Dean, A Turner, P Kelly, D Lubman, G Carter, A Baker, V Manning, T Thomas, R Bathish, D Raftery, L Saunders, A Wrobel, A Meehan, B Sinclair, D Reid, S Arunogiri, H Hill, F Cordaro, P Dietze
(2020), pp. 1-7, Drug and alcohol review, Chichester, Eng., C1
R Zazula, M Husain, M Mohebbi, A Walker, I Chaudhry, A Khoso, M Ashton, B Agustini, N Husain, J Deakin, A Young, M Berk, B Kanchanatawan, C Ng, M Maes, L Berk, A Singh, G Malhi, O Dean
(2020), pp. 1-15, Australian and New Zealand Journal of Psychiatry, London, Eng., C1
Transcriptional effects of psychoactive drugs on genes involved in neurogenesis
Chiara Bortolasci, Briana Randall, Srisaiyini Kidnapillai, Timothy Connor, Trang Truong, Z Liu, Bruna Panizzutti Parry, Mark Richardson, Laura Gray, Michael Berk, Olivia Dean, Ken Walder
(2020), Vol. 21, International Journal of Molecular Sciences, Basel, Switzerland, C1
J Scott, A Baker, C Lim, S Foley, F Dark, A Gordon, D Ward, D Richardson, G Bruxner, K Beckmann, S Hatherill, S Stathis, K Dixon, A Ryan, B McWhinney, J Ungerer, M Berk, O Dean, S Saha, J McGrath
(2020), Vol. 3, pp. 1-11, JAMA network open, Chicago, Ill., C1
Alyna Turner, Andrea Baker, Olivia Dean, Adam Walker, Seetal Dodd, Susan Cotton, James Scott, Bianca Kavanagh, Melanie Ashton, Ellie Brown, John McGrath, Michael Berk
(2020), The Canadian Journal of Psychiatry, Thousand Oaks, Calif., C1
O Dean, K Gray, Seetal Dodd, K Villagonzalo, E Browne, B Tonge, M Berk, L Byrne
(2019), Vol. 44, pp. 474-480, Journal of intellectual and developmental disability, London, Eng., C1
Melanie Ashton, Michael Berk, Chee Ng, Malcolm Hopwood, Seetal Dodd, Alyna Turner, Ellie Brown, Felice Jacka, Susan Cotton, Jon-Paul Khoo, Mary Chatterton, Bianca Kavanagh, Sarah Nadjidai, Samantha Lo Monaco, Brian Harvey, Jerome Sarris, Gin Malhi, Nathan Dowling, Olivia Dean
(2019), Vol. 41, pp. 245-253, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1
Pernille Ellegaard, Rasmus Licht, René Nielsen, Olivia Dean, Michael Berk, Henrik Poulsen, Mohammadreza Mohebbi, Connie Nielsen
(2019), Vol. 245, pp. 1043-1051, Journal of affective disorders, Amsterdam, The Netherlands, C1
Michael Berk, Alyna Turner, Gin Malhi, Chee Ng, Susan Cotton, Seetal Dodd, Yuval Samuni, Michelle Tanious, Claire McAulay, Nathan Dowling, Jerome Sarris, Lauren Owen, Astrid Waterdrinker, Deidre Smith, Olivia Dean
(2019), Vol. 17, pp. 1-11, BMC medicine, London, Eng., C1
Melanie Ashton, Olivia Dean, Adam Walker, Chiara Bortolasci, Chee Ng, Malcolm Hopwood, Brian Harvey, Marisa Möller, John McGrath, Wolfgang Marx, Alyna Turner, Seetal Dodd, James Scott, Jon-Paul Khoo, Ken Walder, Jerome Sarris, Michael Berk
(2019), Vol. 10, pp. 1-17, Frontiers in psychiatry, Lausanne, Switzerland, C1
Alyna Turner, John McGrath, Olivia Dean, Seetal Dodd, Andrea Baker, Susan Cotton, James Scott, Bianca Kavanagh, Melanie Ashton, Adam Walker, Ellie Brown, Michael Berk
(2019), Vol. 17, pp. 297-307, Clinical psychopharmacology and neuroscience, Seoul, South Korea, C1
Melanie Ashton, Michael Berk, Chee Ng, Malcolm Hopwood, Bianca Kavanagh, Lana Williams, Jerome Sarris, Olivia Dean
(2019), Vol. 9, BMJ Open, London, Eng., C1
Carmen Lim, Andrea Baker, Sukanta Saha, Sharon Foley, Anne Gordon, David Ward, Bjorn Burgher, Frances Dark, Martin Beckmann, Stephen Stathis, George Bruxner, Alex Ryan, Drew Richardson, Sean Hatherill, Michael Berk, Olivia Dean, John McGrath, Cadence Working Group, James Scott
(2019), Vol. 20, Trials, London, Eng., C1
Bianca Kavanagh, Sharon Brennan-Olsen, Alyna Turner, Olivia Dean, Michael Berk, Melanie Ashton, Heli Koivumaa-Honkanen, Lana Williams
(2019), Vol. 9, BMJ open, London, Eng., C1
Wolfgang Marx, Melissa Lane, Tetyana Rocks, Anu Ruusunen, Amy Loughman, Adrian Lopresti, Skye Marshall, Michael Berk, Felice Jacka, Olivia Dean
(2019), Vol. 77, pp. 557-571, Nutrition reviews, Oxford, Eng., C1
Rebecca McKetin, Olivia Dean, Alyna Turner, Peter Kelly, Brendan Quinn, Dan Lubman, Paul Dietze, Gregory Carter, Peter Higgs, Amanda Baker, Barbara Sinclair, David Reid, Victoria Manning, Nina Te Pas, Wenbin Liang, Tamsin Thomas, Ramez Bathish, Margaret Kent, Dayle Raftery, Shalini Arunogiri, Frank Cordaro, Harry Hill, Michael Berk
(2019), Vol. 20, pp. 1-11, Trials, London, Eng., C1
D Raftery, P Kelly, F Deane, R Mcketin, A Baker, A Turner, O Dean
(2019), Vol. 38, pp. 622-629, Drug and alcohol review, Chichester, Eng., C1
C Davey, A Chanen, S Hetrick, S Cotton, A Ratheesh, G Amminger, J Koutsogiannis, M Phelan, E Mullen, B Harrison, S Rice, A Parker, O Dean, A Weller, M Kerr, A Quinn, L Catania, N Kazantzis, P McGorry, M Berk
(2019), Vol. 6, pp. 735-744, The Lancet Psychiatry, Amsterdam, The Netherlands, C1
Modulation of high fat diet-induced microbiome changes, but not behaviour, by minocycline
K Hasebe, L Rivera, C Smith, T Allnutt, T Crowley, T Nelson, O Dean, S McGee, K Walder, L Gray
(2019), Vol. 82, pp. 309-318, Brain, behavior, and immunity, Amsterdam, The Netherlands, C1
L Arancini, C Bortolasci, S Dodd, O Dean, M Berk
(2019), Vol. 20, pp. 1-7, Trials, London, Eng., C1
S Kidnapillai, C Bortolasci, B Panizzutti, B Spolding, T Connor, K Bonifacio, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder
(2019), Vol. 20, pp. 766-777, World Journal of Biological Psychiatry, London, Eng., C1
Staging of Schizophrenia with the Use of PANSS: An International Multi-Center Study
K Fountoulakis, E Dragioti, A Theofilidis, T Wikilund, X Atmatzidis, I Nimatoudis, E Thys, M Wampers, L Hranov, T Hristova, D Aptalidis, R Milev, F Iftene, F Spaniel, P Knytl, P Furstova, T From, H Karlsson, M Walta, R Salokangas, J Azorin, J Bouniard, J Montant, G Juckel, I Haussleiter, A Douzenis, I Michopoulos, P Ferentinos, N Smyrnis, L Mantonakis, Z Nemes, X Gonda, D Vajda, A Juhasz, A Shrivastava, J Waddington, M Pompili, A Comparelli, V Corigliano, E Rancans, A Navickas, J Hilbig, L Bukelskis, L Injac Stevovic, S Vodopic, O Esan, O Oladele, C Osunbote, J Rybakowski, P Wojciak, K Domowicz, M Figueira, L Linhares, J Crawford, A Panfil, D Smirnova, O Izmailova, D Lecic-Tosevski, H Temmingh, F Howells, J Bobes, M Garcia-Portilla, L García-Alvarez, G Erzin, H Karadaǧ, A De Sousa, A Bendre, C Hoschl, C Bredicean, I Papava, O Vukovic, B Pejuskovic, V Russell, L Athanasiadis, A Konsta, D Stein, M Berk, O Dean, R Tandon, S Kasper, M De Hert
(2019), Vol. 22, pp. 681-697, International Journal of Neuropsychopharmacology, Oxford, Eng., C1
S Cotton, M Berk, A Watson, S Wood, K Allott, C Bartholomeusz, C Bortolasci, K Walder, B O'Donoghue, O Dean, A Chanen, G Amminger, P McGorry, A Burnside, J Uren, A Ratheesh, S Dodd
(2019), Vol. 20, pp. 1-14, Trials, London, Eng., C1
A Quinn, O Dean, C Davey, M Kerr, S Harrigan, S Cotton, A Chanen, S Dodd, A Ratheesh, G Amminger, M Phelan, A Williams, A Mackinnon, F Giorlando, S Baird, S Rice, M O'Shea, M Schäfer, E Mullen, S Hetrick, P McGorry, M Berk
(2018), Vol. 12, pp. 45-54, Early intervention in psychiatry, London, Eng., C1
I Oberholzer, M Möller, B Holland, O Dean, M Berk, B Harvey
(2018), Vol. 33, pp. 467-480, Metabolic brain disease, New York, N.Y., C1
D Skvarc, M Berk, L Byrne, O Dean, S Dodd, M Lewis, A Marriott, E Moore, G Morris, R Page, L Gray
(2018), Vol. 84, pp. 116-133, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
An update on adjunctive treatment options for bipolar disorder
O Dean, E Gliddon, T Van Rheenen, F Giorlando, S Davidson, M Kaur, T Ngo, L Williams
(2018), Vol. 20, pp. 87-96, Bipolar disorders, Chichester, Eng., C1
Mechanisms underpinning the polypharmacy effects of medications in psychiatry
Chiara Bortolasci, Briana Spolding, Edward Callaly, Sheree Martin, Bruna Panizzutti, Srisaiyini Kidnapillai, Timothy Connor, Kyoko Hasebe, Mohammadreza Mohebbi, Olivia Dean, Sean McGee, Seetal Dodd, Laura Gray, Michael Berk, Ken Walder
(2018), Vol. 21, pp. 582-591, The international journal of neuropsychopharmacology, Oxford, Eng., C1
Mitochondrial agents for bipolar disorder
Círia Pereira, Victor Chavarria, João Vian, Melanie Ashton, Michael Berk, Wolfgang Marx, Olivia Dean
(2018), Vol. 21, pp. 550-569, International journal of neuropsychopharmacology, London, Eng., C1
P Ellegaard, R Licht, H Poulsen, R Nielsen, M Berk, O Dean, M Mohebbi, C Nielsen
(2018), Vol. 6, pp. 1-9, International journal of bipolar disorders, Berlin, Germany, C1
M Mohebbi, S Dodd, O Dean, M Berk
(2018), Vol. 53, pp. 17-22, European psychiatry, Amsterdam, The Netherlands, C1
The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder
Srisaiyini Kidnapillai, Chiara Bortolasci, Madhara Udawela, Bruna Panizzutti, Briana Spolding, Timothy Connor, Andrew Sanigorski, Olivia Dean, Tamsyn Crowley, Stéphane Jamain, Laura Gray, Elizabeth Scarr, Marion Leboyer, Brian Dean, Michael Berk, Ken Walder
(2018), pp. 1-9, World journal of biological psychiatry, London, Eng., C1
Bruna Panizzutti, Chiara Bortolasci, Kyoko Hasebe, Srisaiyini Kidnapillai, Laura Gray, Ken Walder, Michael Berk, Mohammadreza Mohebbi, Seetal Dodd, Clarissa Gama, Pedro Magalhães, Susan Cotton, Flávio Kapczinski, Ashley Bush, Gin Malhi, Olivia Dean
(2018), Vol. 30, pp. 334-341, Acta neuropsychiatrica, Cambridge, Eng., C1
A potential role for N-acetylcysteine in the management of methamphetamine dependence
R McKetin, O Dean, A Baker, G Carter, A Turner, P Kelly, M Berk
(2017), Vol. 36, pp. 153-159, Drug and alcohol review, London, Eng., C1
O Dean, K Gray, K-A Villagonzalo, S Dodd, M Mohebbi, T Vick, B Tonge, M Berk
(2017), Vol. 51, pp. 241-249, Australian and New Zealand journal of psychiatry, London, Eng., C1
Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology
J Data-Franco, A Singh, D Popovic, M Ashton, M Berk, E Vieta, M Figueira, O Dean
(2017), Vol. 72, pp. 73-86, Progress in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1
Cognitive effects of adjunctive N-acetyl cysteine in psychosis
M Rapado-Castro, S Dodd, A Bush, G Malhi, D Skvarc, Z On, M Berk, O Dean
(2017), Vol. 47, pp. 866-876, Psychological medicine, Cambridge, Eng., C1
A model of the mitochondrial basis of bipolar disorder
G Morris, K Walder, S McGee, O Dean, S Tye, M Maes, M Berk
(2017), Vol. 74, pp. 1-20, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
F Jacka, A O'Neil, R Opie, C Itsiopoulos, S Cotton, M Mohebbi, D Castle, S Dash, C Mihalopoulos, M Chatterton, L Brazionis, O Dean, A Hodge, M Berk
(2017), Vol. 15, pp. 1-13, BMC medicine, London, Eng., C1
A review of the theoretical and biological understanding of the nocebo and placebo phenomena
S Dodd, O Dean, J Vian, M Berk
(2017), Vol. 39, pp. 469-476, Clinical therapeutics, Amsterdam, The Netherlands, C1
K Hasebe, L Gray, C Bortolasci, B Panizzutti, M Mohebbi, S Kidnapillai, B Spolding, K Walder, M Berk, G Malhi, S Dodd, O Dean
(2017), Vol. 29, pp. 337-346, Acta neuropsychiatrica, Cambridge, Eng., C1
A Ryan, A Baker, F Dark, S Foley, A Gordon, S Hatherill, S Stathis, S Saha, G Bruxner, M Beckman, D Richardson, M Berk, O Dean, J McGrath, Cadence Working Group, J Scott
(2017), Vol. 18, pp. 1-11, Trials, London, Eng., C1
the effect of n-acetylcysteine (nac) on human cognition - a systematic review
D Skvarc, O Dean, L Byrne, L Gray, S Lane, M Lewis, B Fernandes, M Berk, A Marriott
(2017), Vol. 78, pp. 44-56, Neuroscience & Biobehavioral Reviews, Amsterdam, The Netherlands, C1
Adjunctive minocycline treatment for major depressive disorder: a proof of concept trial
O Dean, B Kanchanatawan, M Ashton, M Mohebbi, C Ng, M Maes, L Berk, A Sughondhabirom, S Tangwongchai, A Singh, H McKenzie, D Smith, G Malhi, N Dowling, M Berk
(2017), Vol. 51, pp. 829-840, Australian & New Zealand journal of psychiatry, London, Eng., C1
R Menon, L Cribb, J Murphy, M Ashton, G Oliver, N Dowling, A Turner, O Dean, M Berk, C Ng, J Sarris
(2017), Vol. 4, pp. 109-114, Advances in integrative medicine, Amsterdam, The Netherlands, C1
B Fernandes, J Steiner, H Bernstein, S Dodd, J Pasco, O Dean, P Nardin, C Gonçalves, M Berk
(2016), Vol. 21, pp. 554-564, Molecular psychiatry, London, Eng., C1
A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis
J Davis, H Eyre, F Jacka, S Dodd, O Dean, S McEwen, M Debnath, J McGrath, M Maes, P Amminger, P McGorry, C Pantelis, M Berk
(2016), Vol. 65, pp. 185-194, Neuroscience & biobehavioral reviews, Amsterdam, The Netherlands, C1
Antioxidant treatments for schizophrenia
P Magalhães, O Dean, A Andreazza, M Berk, F Kapczinski
(2016), Vol. 2016, pp. 1-93, Cochrane database of systematic reviews, London, Eng., C1
N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis
B Fernandes, O Dean, S Dodd, G Malhi, M Berk
(2016), Vol. 77, pp. 457-466, Journal of clinical psychiatry, Memphis, Tenn., C1
D Skvarc, O Dean, L Byrne, L Gray, K Ives, S Lane, M Lewis, C Osborne, R Page, D Stupart, A Turner, M Berk, A Marriott
(2016), Vol. 17, pp. 1-11, Trials, London, Eng., C1
S Rossell, P Francis, C Galletly, A Harris, D Siskind, M Berk, K Bozaoglu, F Dark, O Dean, D Liu, D Meyer, E Neill, A Phillipou, J Sarris, D Castle
(2016), Vol. 16, pp. 1-9, BMC psychiatry, London, Eng., C1
J Sarris, G Oliver, D Camfield, O Dean
(2016), Vol. 4, pp. 1104-1111, Clinical psychological science, London, Eng., C1
The use of mixed methods in drug discovery: integrating qualitative methods into clinical trials
M Berk, R Otmar, O Dean, L Berk, E Michalak
(2015), pp. 59-73, Clinical trial design challenges in mood disorders, Amsterdam, The Netherlands, B1
M Rapado-Castro, M Berk, K Venugopal, A Bush, S Dodd, O Dean
(2015), Vol. 57, pp. 69-75, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1
Oxidative stress and post-stroke depression: possible therapeutic role of polyphenols?
S Nabavi, O Dean, A Turner, A Sureda, M Daglia, S Nabavi
(2015), Vol. 22, pp. 343-351, Current medicinal chemistry, Beijing, China, C1-1
Tobacco use in bipolar disorder.
D Thomson, M Berk, S Dodd, M Rapado-Castro, S Quirk, P Ellegaard, L Berk, O Dean
(2015), Vol. 13, pp. 1-11, Clinical Psychopharmacology and Neuroscience, Korea (South), C1
G Oliver, O Dean, D Camfield, S Blair-West, C Ng, M Berk, J Sarris
(2015), Vol. 13, pp. 12-24, Clinical psychopharmacology and neuroscience, Korea (South), C1
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
Deepmala, J Slattery, N Kumar, L Delhey, M Berk, O Dean, C Spielholz, R Frye
(2015), Vol. 55, pp. 294-321, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1
J Sarris, G Oliver, D Camfield, O Dean, N Dowling, D Smith, J Murphy, R Menon, M Berk, S Blair-West, C Ng
(2015), Vol. 29, pp. 801-809, CNS Drugs, Berlin, Germany, C1
Future directions for pharmacotherapies for treatment-resistant bipolar disorder
S Dodd, B Simoes Fernandes, O Dean
(2015), Vol. 13, pp. 656-662, Current neuropharmacology, Bussum, The Netherlands, C1
G Anderson, M Berk, O Dean, S Moylan, M Maes
(2014), Vol. 28, pp. 1-10, CNS Drugs, C1
Post-stroke depression therapy: Where are we now?
S Nabavi, A Turner, O Dean, A Sureda, S Nabavi
(2014), Vol. 11, pp. 279-289, Current Neurovascular Research, C1
M Berk, O Dean, S Cotton, S Jeavons, M Tanious, K Kohlmann, K Hewitt, K Moss, C Allwang, I Schapkaitz, J Robbins, H Cobb, F Ng, S Dodd, A Bush, G Malhi
(2014), Vol. 75, pp. 628-636, Journal of clinical psychiatry, Memphis, Tenn., C1
Oxidative & nitrosative stress in depression: why so much stress?
S Moylan, M Berk, O Dean, Y Samuni, L Williams, A O'Neil, A Hayley, J Pasco, G Anderson, F Jacka, M Maes
(2014), Vol. 45, pp. 46-62, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
O Dean, A Turner, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, Y Samuni, M Tanious, N Dowling, A Waterdrinker, D Smith, M Berk
(2014), Vol. 0, pp. 1-10, Revista Brasileira de psiquiatria, Sao Paulo, Brazil, C1
The Glutathione System: a new drug target in neuroimmune disorders
G Morris, G Morris, G Anderson, G Anderson, O Dean, O Dean, M Berk, M Berk, P Galecki, P Galecki, M Martin-Subero, M Martin-Subero, M Maes, M Maes
(2014), Vol. 50, pp. 1059-1084, Molecular neurobiology, New York, N. Y., C1
C Davey, A Chanen, S Cotton, S Hetrick, M Kerr, M Berk, O Dean, K Yuen, M Phelan, A Ratheesh, M Schäfer, G Amminger, A Parker, D Piskulic, S Harrigan, A Mackinnon, B Harrison, P McGorry
(2014), Vol. 15, pp. 1-9, Trials, London, Eng., C1
O Dean, M Maes, M Ashton, L Berk, B Kanchanatawan, A Sughondhabirom, S Tangwongchai, C Ng, N Dowling, G Malhi, M Berk
(2014), Vol. 12, pp. 180-188, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1
Putative neuroprotective agents in neuropsychiatric disorders
S Dodd, M Maes, G Anderson, O Dean, S Moylan, M Berk
(2013), Vol. 42, pp. 135-145, Progress in Neuro-Psychopharmacology and Biological Psychiatry, C1
The promise of N-acetylcysteine in neuropsychiatry
M Berk, G Malhi, L Gray, O Dean
(2013), Vol. 34, pp. 167-177, Trends in Pharmacological Sciences, C1
P Das, M Tanious, K Fritz, S Dodd, O Dean, M Berk, G Malhi
(2013), Vol. 47, pp. 347-354, Australian and New Zealand Journal of Psychiatry, C1
A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania
P Da Silva Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2013), Vol. 47, pp. 564-568, Australian and New Zealand Journal of Psychiatry, C1
Aspirin: A review of its neurobiological properties and therapeutic potential for mental illness
M Berk, M Berk, O Dean, O Dean, H Drexhage, H Drexhage, J McNeil, J McNeil, S Moylan, S Moylan, A O'Neil, A O'Neil, C Davey, C Davey, L Sanna, L Sanna, M Maes, M Maes
(2013), Vol. 11, pp. 1-17, BMC Medicine, C1
A O'Neil, M Berk, C Itsiopoulos, D Castle, R Opie, J Pizzinga, L Brazionis, A Hodge, C Mihalopoulos, M Chatterton, O Dean, F Jacka
(2013), Vol. 13, BMC Psychiatry, C1
The chemistry and biological activities of N-acetylcysteine
Y Samuni, S Goldstein, O Dean, M Berk
(2013), Vol. 1830, pp. 4117-4129, Biochimica et Biophysica Acta - General Subjects, C1
H Kalra, O Dean, S Dodd, M Berk
(2012), pp. 95-107, Antidepressants and Major Depressive Disorder, B1-1
Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder
P Magalhães, O Dean, A Bush, D Copolov, D Weisinger, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2012), Vol. 37, pp. 132-135, Progress in Neuro-Psychopharmacology and Biological Psychiatry, C1
Minocycline: Therapeutic potential in psychiatry
O Dean, J Data-Franco, F Giorlando, M Berk
(2012), Vol. 26, pp. 391-401, CNS Drugs, C1
M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, K Moss, C Allwang, I Schapkaitz, H Cobb, A Bush, S Dodd, G Malhi
(2012), Vol. 10, BMC Medicine, C1
Effects of N-acetyl cysteine on cognitive function in bipolar disorder
O Dean, A Bush, D Copolov, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2012), Vol. 66, pp. 514-517, Psychiatry and Clinical Neurosciences, C1
M Berk, A Munib, O Dean, G Malhi, K Kohlmann, I Schapkaitz, S Jeavons, F Katz, M Anderson-Hunt, P Conus, B Hanna, R Otmar, F Ng, D Copolov, A Bush
(2011), Vol. 72, pp. 909-913, Journal of clinical psychiatry, [Memphis, Tenn.], C1-1
N-acetylcysteine in psychiatry: Current therapeutic evidence and potential mechanisms of action
O Dean, F Giorlando, M Berk
(2011), Vol. 36, pp. 78-86, Journal of Psychiatry and Neuroscience, C1-1
O Dean, M Van Den Buuse, M Berk, D Copolov, C Mavros, A Bush
(2011), Vol. 499, pp. 149-153, Neuroscience Letters, C1-1
M Gerlach, G Bartoszyk, P Riederer, O Dean, M Van Den Buuse
(2011), Vol. 118, pp. 1733-1742, Journal of Neural Transmission, C1-1
P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2011), Vol. 129, pp. 317-320, Journal of Affective Disorders, C1-1
Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder
P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2011), Vol. 23, pp. 87-88, Acta Neuropsychiatrica, C1-1
M Berk, F Kapczinski, A Andreazza, O Dean, F Giorlando, M Maes, M Yücel, C Gama, S Dodd, B Dean, P Magalhães, P Amminger, P McGorry, G Malhi
(2011), Vol. 35, pp. 804-817, Neuroscience and Biobehavioral Reviews, C1-1
M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, C Allwang, H Cobb, A Bush, I Schapkaitz, S Dodd, G Malhi
(2011), Vol. 135, pp. 389-394, Journal of Affective Disorders, C1
Who's left? Symptoms of schizophrenia that predict clinical trial dropout
J Thompson, M Berk, O Dean, K Kohlmann, S Jeavons, A Bush, D Copolov
(2011), Vol. 26, pp. 609-613, Human Psychopharmacology, C1-1
N-acetylcysteine for major depressive episodes in bipolar disorder
P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2011), Vol. 33, pp. 374-378, Revista Brasileira de Psiquiatria, C1
K Choy, O Dean, M Berk, A Bush, M van den Buuse
(2010), Vol. 649, pp. 224-228, European Journal of Pharmacology, C1-1
O Dean, A Bush, M Berk, D Copolov, M van den Buuse
(2010), Vol. 97, pp. 293-300, Pharmacology Biochemistry and Behavior, C1-1
Oxidative pathways as a drug target for the treatment of autism
K Villagonzalo, S Dodd, O Dean, K Gray, B Tonge, M Berk
(2010), Vol. 14, pp. 1301-1310, Expert Opinion on Therapeutic Targets, C1-1
M Berk, S Dodd, O Dean, K Kohlmann, L Berk, G Malhi
(2010), Vol. 22, pp. 237-242, Acta Neuropsychiatrica, C1-1
Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting
M Berk, S Jeavons, O Dean, S Dodd, K Moss, C Gama, G Malhi
(2009), Vol. 14, pp. 357-360, CNS Spectrums, C1-1
Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice
O Dean, A Bush, M Berk, D Copolov, M van den Buuse
(2009), Vol. 198, pp. 258-262, Behavioural Brain Research, C1-1
O Dean, M van den Buuse, A Bush, D Copolov, F Ng, S Dodd, M Berk
(2009), Vol. 16, pp. 2965-2976, Current Medicinal Chemistry, C1-1
M Bernardo, S Dodd, C Gama, D Copolov, O Dean, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush, M Berk
(2009), Vol. 21, pp. 239-245, Acta Neuropsychiatrica, C1-1
M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush
(2008), Vol. 64, pp. 468-475, Biological Psychiatry, C1-1
M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, F Judd, F Katz, P Katz, S Ording-Jespersen, J Little, P Conus, M Cuenod, K Do, A Bush
(2008), Vol. 64, pp. 361-368, Biological Psychiatry, C1-1
Glutathione: a novel treatment target in psychiatry
M Berk, F Ng, O Dean, S Dodd, A Bush
(2008), Vol. 29, pp. 346-351, Trends in Pharmacological Sciences, C1-1
Oxidative stress in psychiatric disorders: Evidence base and therapeutic implications
F Ng, M Berk, O Dean, A Bush
(2008), Vol. 11, pp. 851-876, International Journal of Neuropsychopharmacology, C1-1
N-acetylcysteine for antioxidant therapy: Pharmacology and clinical utility
S Dodd, O Dean, D Copolov, G Malhi, M Berk
(2008), Vol. 8, pp. 1955-1962, Expert Opinion on Biological Therapy, C1-1
M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, F Judd, F Katz, P Katz, S Ording-Jespersen, J Little, P Conus, M Cuenod, K Do, A Bush
(2008), Vol. 64, pp. 361-368, Biological Psychiatry, Philadelphia, Pa., C1-1
S Jespersen, M Berk, C Van Wyk, O Dean, S Dodd, C Szabo, C Maud
(2004), Vol. 19, pp. 161-164, International Clinical Psychopharmacology, C1-1
Adjunctive antioxidants for bipolar disorder
Pedro Magalhães, Olivia Dean, Ana Andreazza, Michael Berk, Flávio Kapczinski
(), Cochrane Database of Systematic Reviews, C1-1
Antioxidant treatments for schizophrenia
Pedro Magalhães, Ana Andreazza, Michael Berk, Flávio Kapczinski, Olivia Dean
(), C1-1
Funded Projects at Deakin
Australian Competitive Grants
The Efficacy of N-acetylcysteine as an Adjunctive Treatment in Bipolar Depression: A Double-blind, Randomised, Placebo-controlled Trial
Prof Michael Berk, A/Prof Olivia Dean, A/Prof Susan Cotton, Dr Seetal Dodd, Prof Gin Malhi, A/Prof Chee Ng
NHMRC Project Grant
- 2015: $69,545
- 2014: $169,437
- 2013: $74,883
- 2012: $197,858
The Efficacy of N-acetylcysteine as an adjunctive treatment in unipolar depression
Prof Michael Berk, Prof Gin Malhi, Dr Seetal Dodd, A/Prof Olivia Dean
NHMRC Project Grant
- 2012: $32,725
- 2011: $48,924
Proof of principle of the inflammatory and oxidative theory of depression: A treatment study
Prof Michael Berk, Dr Andrew Chanen, Ms Susan Harrigan, Mr Christopher Davey, Dr Sarah Hetrick, A/Prof Olivia Dean, Dr Seetal Dodd
NHMRC Project Grant
- 2018: $20,933
- 2017: $102,975
- 2016: $152,181
- 2015: $110,745
- 2014: $111,704
- 2013: $105,227
- 2012: $26,547
The efficacy of adjunctive Garcinia mangostana Linn. pericarp for bipolar depression: A 24-week double-blind, randomized, placebo-controlled trial.
A/Prof Olivia Dean, Prof Michael Berk, A/Prof Chee Ng, Dr Seetal Dodd, Prof Malcolm Hopwood, Dr Alyna Turner, Prof Felice Jacka
NHMRC Project Grant
- 2020: $76,202
- 2019: $264,142
- 2018: $342,644
- 2017: $209,758
Integrated exploration of novel therapies for depression
A/Prof Olivia Dean
NHMRC CDF - Career Development Fellowship
- 2021: $36,519
- 2020: $124,380
- 2019: $122,663
- 2018: $120,850
The N-ICE trial: A randomised controlled trial of the safety and efficacy of N-Acetyl Cysteine (NAC) as a pharmacotherapy for methamphetamine ('ice'¿) dependence
A/Prof Rebecca McKetin, A/Prof Olivia Dean, Prof Dan Lubman, Prof Paul Dietze, Dr Peter Higgs, Dr Peter Kelly, Dr Alyna Turner, Dr Brendan Quinn, Prof Greg Carter
NHMRC Project Grant
- 2019: $138,332
- 2018: $153,853
- 2017: $71,859
CREDIT: The CRE for the Development of Innovative Therapies for Psychiatric Disorders
Prof Michael Berk, Prof John McGrath, Prof Patrick McGorry, Prof John McNeil, Prof Gin Malhi, Prof Felice Jacka, A/Prof Susan Cotton, Prof Ken Walder, A/Prof Olivia Dean, A/Prof Lana Williams
NHMRC - Centres of Research Excellence
- 2021: $135,974
- 2020: $576,585
- 2019: $510,344
Other Public Sector Funding
Refrigerated Centrifuge and Vortex
Prof Michael Berk, A/Prof Olivia Dean
- 2015: $8,187
Industry and Other Funding
Efficacy of N-Acetyl Cysteine in Autism: A double blind, placebo-controlled randomised trial
Prof Michael Berk, Dr Seetal Dodd, A/Prof Olivia Dean, Dr Katherine Gray, Prof Bruce Tonge
- 2013: $143,821
- 2012: $119,640
The Efficacy of Minocycline as an Adjunctive Treatment in Unipolar Depression: A Pilot Study
A/Prof Olivia Dean
- 2014: $10,000
- 2013: $10,000
- 2012: $10,000
The efficacy of minocycline as an adjunctive therapy for unipolar depression: A pilot study.
A/Prof Olivia Dean
- 2014: $35,973
- 2013: $13,966
The efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for the treatment of Schizophrenia: A double-blind, randomized, placebo controlled trial.
Prof Michael Berk, Dr Seetal Dodd, A/Prof Olivia Dean, Dr Alyna Turner, A/Prof Susan Cotton, Prof John McGrath, Dr Frances Dark
- 2021: $117,491
- 2019: $96,709
- 2018: $167,831
- 2017: $363,170
- 2016: $239,559
Exploring inflammation in depression ¿ Minocycline compared with N-acetyl cysteine.
A/Prof Olivia Dean
- 2017: $10,000
- 2016: $20,000
The efficacy of adjunctive Garcinia mangostana linn (mangosteen) pericarp for bipolar depression: A 24-week double-blind, randomised, placebo controlled trial
A/Prof Olivia Dean, Dr Melanie Ashton
- 2017: $4,250
- 2016: $30,000
The efficacy of adjunctive Garcinia mangostana linn (mangosteen) pericarp for bipolar depression: A 24-week double-blind, randomised, placebo controlled trial
A/Prof Olivia Dean, Prof Michael Berk, Dr Melanie Ashton
- 2019: $15,750
- 2018: $17,000
- 2017: $13,136
- 2016: $3,863
Can we reduce tobacco smoking using N-acetylcysteine as a cessation treatment?
Prof Michael Berk, Dr Seetal Dodd, A/Prof Olivia Dean
- 2018: $25,000
- 2017: $25,000
Trisno Family Postdoctoral Mental Health Research Fellowship
A/Prof Olivia Dean
- 2019: $30,000
"Resuming Employment after Stroke: Enhancement through Telecoordination" - RESET Rural Expansion
Dr Alyna Turner, A/Prof Olivia Dean, Dr Alison Kennedy, Dr Mohammadreza Mohebbi, Dr Lan Gao
- 2021: $74,945
Supervisions
Melanie Ashton
Thesis entitled: Exploring factors that contribute to treatment response in bipolar depression
Doctor of Philosophy (Medicine), School of Medicine
Bianca Kavanagh
Thesis entitled: Impact of Personality Disorder on Health, Functioning, and Treatment Outcomes
Doctor of Philosophy (Medicine), School of Medicine
Declan Bourke
Thesis entitled: Predictors and moderators of treatment efficacy for childhood disruptive behaviours
Doctor of Psychology (Clinical), School of Psychology
David Robert Skvarc
Thesis entitled: The Post-Anaesthesia N-Acetyl-Cysteine Cognitive Evaluation (PANACEA) trial
Doctor of Philosophy (Psychology), School of Psychology
Kyoko Hasebe
Thesis entitled: Investigating Neurobiological Mechanisms Linking Depression and Inflammation
Doctor of Philosophy (Medicine), School of Medicine